ArticleInternational journal of radiation oncology, biology, physics2026
Radiation Doses to Cardiac Substructures Predict Elevation in High-sensitivity Cardiac Troponin T Levels in Radiation Therapy for Lung Cancer.
Article in International journal of radiation oncology, biology, physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
Abstract
purposeCardiotoxicity is a major concern for patients undergoing thoracic radiation therapy. This study compared the predictive power of radiation dose-volume histogram (DVH) parameters and radiomic/dosiomic features of the whole heart (WH) and cardiac substructures for elevated circulating high-sensitivity cardiac troponin T (hs-cTnT), a biomarker for early detection of cardiac adverse events. METHODS AND MATERIALS: A retrospective cohort of 160 patients with non-small cell lung cancer (NSCLC) from a completed prospective trial and a prospective cohort of 57 patients with NSCLC enrolled in an ongoing trial were analyzed. The endpoint was hs-cTnT elevation, indicated by an increase of ≥5 ng/L from baseline. An in-house auto-segmentation model delineated 19 cardiac substructures. DVH parameters, radiomic, and dosiomic features were extracted from each patient. A 100-iteration Monte Carlo cross-validation (75%/25% split) was conducted within the retrospective cohort to mitigate random split bias. Logistic regression models using different input combinations were compared, with a model using only clinical factors serving as the baseline. Key predictive features were identified using permutation importance during training. Models were validated by holdout in the prospective cohort to evaluate robustness. Model performance was assessed by the area under the receiver operating characteristic curve (AUROC).
resultsIncidence of hs-cTnT elevation was 31.9% in the retrospective and 29.8% in the prospective cohort. The substructure DVH model achieved the highest predictive performance in cross-validation (mean AUROC, 0.71; 95% CI, 0.70-0.73) and demonstrated greater robustness in holdout validation compared with WH-based models (AUROC: 0.60 vs ≤0.51). Feature analysis identified the left anterior descending coronary artery V20Gy as the most dominant predictor, with cutoff values ranging from 0.2% to 5% using various indices.
conclusionsCardiac substructure DVH parameters have superior predictive power and robustness over WH variables for predicting hs-cTnT elevation in NSCLC radiation therapy, emphasizing the need to use cardiac substructures for cardiotoxicity risk assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.